PDF(2060 KB)
溴化结构域蛋白抑制剂JQ1对哮喘小鼠气道重塑作用机制研究
朱晓华, 李秋根, 汪俊, 胡国柱, 刘志强, 胡清华, 吴刚
中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (12) : 1278-1284.
PDF(2060 KB)
PDF(2060 KB)
溴化结构域蛋白抑制剂JQ1对哮喘小鼠气道重塑作用机制研究
Mechanism of action of BET bromodomain inhibitor JQ1 in treating airway remodeling in asthmatic mice
目的 探讨溴化结构域蛋白抑制剂JQ1对哮喘小鼠气道重塑治疗的分子学机制。方法 将24只小鼠随机分成对照组、OVA诱导哮喘组（OVA组）、JQ1干预哮喘组（JQ1+OVA组）（n=8）。采用OVA致敏/激发制备哮喘小鼠模型，雾化激发前1 h，JQ1+OVA组小鼠经腹腔注射JQ1溶液（50 μg/g）。末次激发24 h后留取支气管肺泡灌洗液（BALF）及肺组织，计算各组BALF中细胞总数及嗜酸性粒细胞百分比，肺组织行病理染色观察各组小鼠肺组织病理改变；采用RT-PCR及Western blot法分别检测小鼠肺上皮间质转化（EMT）过程中钙黏蛋白（E-Cadherin）、波形蛋白（vimentin）mRNA及蛋白水平的表达变化。结果 与对照组比较，OVA组小鼠气道炎性细胞明显浸润，气道壁增厚，黏液渗出增多；BALF中细胞总数增加，嗜酸性粒细胞百分比增多（P < 0.01）。与OVA组比较，JQ1+OVA组小鼠气道炎症反应明显减轻；BALF中细胞总数明显减少，嗜酸性粒细胞百分比降低（P < 0.01）。与对照组比较，OVA组小鼠肺组织气道上皮E-Cadherin mRNA及蛋白表达水平明显下调，vimentin mRNA及蛋白表达水平明显上调（P < 0.01）；与OVA组比较，JQ1+OVA组E-Cadherin mRNA及蛋白表达水平升高，vimentin mRNA及蛋白表达水平下降（P < 0.01）；JQ1+OVA组与对照组上述指标表达水平比较差异无统计学意义（P > 0.05）。结论 OVA哮喘小鼠存在EMT气道重塑；溴化结构域蛋白抑制剂JQ1可降低哮喘小鼠气道炎症，抑制EMT，减轻气道重塑，为哮喘治疗提供了一个潜在的新方向。
Objective To investigate the molecular mechanism of action of BET bromodomain inhibitor JQ1 in treating airway remodeling in asthmatic mice. Methods A total of 24 mice were randomly divided into control group, ovalbumin (OVA)-induced asthma group (OVA group), and JQ1 intervention group (JQ1+OVA group), with 8 mice in each group. OVA sensitization/challenge was performed to establish a mouse model of asthma. At 1 hour before challenge, the mice in the JQ1+OVA group were given intraperitoneal injection of JQ1 solution (50 μg/g). Bronchoalveolar lavage fluid (BALF) and lung tissue samples were collected at 24 hours after the last challenge, and the total number of cells and percentage of eosinophils in BALF were calculated. Pathological staining was performed to observe histopathological changes in lung tissue. RT-PCR and Western blot were used to measure the mRNA and protein expression of E-cadherin and vimentin during epithelial-mesenchymal transition (EMT). Results Compared with the control group, the OVA group had marked infiltration of inflammatory cells in the airway, thickening of the airway wall, increased secretion of mucus, and increases in the total number of cells and percentage of eosinophils in BALF (P < 0.01). Compared with the OVA group, the JQ1+OVA group had significantly alleviated airway inflammatory response and significant reductions in the total number of cells and percentage of eosinophils in BALF (P < 0.01). Compared with the control group, the OVA group had significant reductions in the mRNA and protein expression of E-cadherin and significant increases in the mRNA and protein expression of vimentin (P < 0.01); compared with the OVA group, the JQ1+OVA group had significant increases in the mRNA and protein expression of E-cadherin and significant reductions in the mRNA and protein expression of vimentin (P < 0.01); there were no significant differences in these indices between the JQ1+OVA group and the control group (P > 0.05). Conclusions Mice with OVA-induced asthma have airway remodeling during EMT. BET bromodomain inhibitor JQ1 can reduce airway inflammation, inhibit EMT, and alleviate airway remodeling, which provides a new direction for the treatment of asthma.
JQ1 / Asthma / Epithelial-mesenchymal transition / Airway remodeling / Mice
[1] Baldacci S, Maio S, Cerrai S, et al. Allergy and asthma:effects of the exposure to particulate matter and biological allergens[J]. Respir Med, 2015, 109(9):1089-1104.
[2] Bartis D, Thickett DR. Authors' response:epithelial-mesenchymal transition (EMT) is a common molecular programme in epithelial cells which can be triggered by injury[J]. Thorax, 2014, 69(8):769.
[3] Belkina AC, Nikolajczyk BS, Denis GV. BET protein function is required for inflammation:Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses[J]. J Immunol, 2013, 190(7):3670-3678.
[4] Berair R, Brightling CE. Asthma therapy and its effect on airway remodelling[J]. Drugs, 2014, 74(12):1345-1369.
[5] Bid HK, Phelps DA, Xaio L, et al. The bromodomain BET inhibitor JQ1 suppresses tumor angiogenesis in models of childhood sarcoma[J]. Mol Cancer Ther, 2016, 15(5):1018-1028.
[6] Chang H, Liu Y, Xue M, et al. Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition[J]. Nucleic Acids Res, 2016, 44(6):2514-2527.
[7] Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis[J]. Annu Rev Physiol, 2011, 73:413-435.
[8] Chung KF. Targeting the interleukin pathway in the treatment of asthma[J]. Lancet, 2015, 386(9998):1086-1096.
[9] de Boer WI, Sharma HS, Baelemans SM, et al. Altered expression of epithelial junctional proteins in atopic asthma:possible role in inflammation[J]. Can J Physiol Pharmacol, 2008, 86(3):105-112.
[10] Doerner AM, Zuraw BL. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids[J]. Respir Res, 2009, 10:100.
[11] Emadali A, Rousseaux S, Bruder-Costa J, et al. Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers[J]. EMBO Mol Med, 2013, 5(8):1180-1195.
[12] Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains[J]. Nature, 2010, 468(7327):1067-1073.
[13] Fischer KD, Agrawal DK. Vitamin D regulating TGF-β induced epithelial-mesenchymal transition[J]. Respir Res, 2014, 15:146.
[14] Fischer KD, Hall SC, Agrawal DK. Vitamin D supplementation reduces induction of epithelial-mesenchymal transition in allergen sensitized and challenged mice[J]. PLoS One, 2016, 11(2):e0149180.
[15] Folli C, Descalzi D, Scordamaglia F, et al. New insights into airway remodelling in asthma and its possible modulation[J]. Curr Opin Allergy Clin Immunol, 2008, 8(5):367-375.
[16] Hirota N, Martin JG. Mechanisms of airway remodeling[J]. Chest, 2013, 144(3):1026-1032.
[17] Hussong M, Börno ST, Kerick M, et al. The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response[J]. Cell Death Dis, 2014, 5:e1195.
[18] Ijaz T, Pazdrak K, Kalita M, et al. Systems biology approaches to understanding Epithelial Mesenchymal Transition (EMT) in mucosal remodeling and signaling in asthma[J]. World Allergy Organ J, 2014, 7(1):13.
[19] Kalita M, Tian B, Gao B, et al. Systems approaches to modeling chronic mucosal inflammation[J]. Biomed Res Int, 2013, 2013:505864.
[20] Khan YM, Kirkham P, Barnes PJ, et al. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells[J]. PLoS One, 2014, 9(4):e95051.
[21] Khan YM, Kirkham P, Barnes PJ, et al. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells[J]. PLoS One, 2014, 9(4):e95051.
[22] Li M, Luan F, Zhao Y, et al. Epithelial-mesenchymal transition:an emerging target in tissue fibrosis[J]. Exp Biol Med (Maywood), 2016, 241(1):1-13.
[23] Liu T, Liu Y, Miller M, et al. Autophagy plays a role in FSTL1-induced epithelial mesenchymal transition and airway remodeling in asthma[J]. Am J Physiol Lung Cell Mol Physiol, 2017, 313(1):L27-L40.
[24] Nawshad A, Lagamba D, Polad A, et al. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation:implications for embryogenesis and tumor metastasis[J]. Cells Tissues Organs, 2005, 179(1-2):11-23.
[25] Park IH, Kang JH, Shin JM, et al. Trichostatin A inhibits epithelial mesenchymal transition induced by TGF-β1 in airway epithelium[J]. PLoS One, 2016, 11(8):e0162058.
[26] Shahbazi J, Liu PY, Atmadibrata B, et al. The bromodomain inhibitor JQ1 and the histone deacetylase inhibitor panobinostat synergistically reduce N-Myc expression and induce anticancer effects[J]. Clin Cancer Res, 2016, 22(10):2534-2544.
[27] Shim JM, Lee JS, Russell KE, et al. BET proteins are a key component of immunoglobulin gene expression[J]. Epigenomics, 2017, 9(4):393-406.
[28] Tang X, Peng R, Phillips JE, et al. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis[J]. Am J Pathol, 2013, 183(2):470-479.
[29] Wang J, Li FS, Pang NN, et al. Inhibition of asthma in OVA sensitized mice model by a traditional uygur herb nepeta bracteata benth[J]. Evid Based Complement Alternat Med, 2016, 2016:5769897.
[30] Wang L, Wu X, Wang R, et al. BRD4 inhibition suppresses cell growth, migration and invasion of salivary adenoid cystic carcinoma[J]. Biol Res, 2017, 50(1):19.
[31] Wang N, Yan D, Liu Y, et al. A HuR/TGF-β1 feedback circuit regulates airway remodeling in airway smooth muscle cells[J]. Respir Res, 2016, 17(1):117.
江西省科技厅重大科研基金（20151BBB70267）。
